Vizient announces that Curt Nonomaque, president and CEO, plans to retire after serving in his role for nearly 15 years.Byron Jobe, Vizient’s current president, chief administrative and...
Vizient, Inc. proud to extend relationship with Lifespan, in Providence, Rhode Island....
Americans would pay an extra $10.7 billion if a generic version of Restasis is unavailable between 2018 and 2024, when the existing patents on the medicine are due to expire
Vizient, Inc. proud to continue relationship with Vanderbilt University Medical Center in Nashville, Tennessee. This relationship will help Vanderbilt achieve the highest quality...
It seems that no side – payers, hospitals or suppliers – wants to be stuck alone at the end managing the high cost of care in the joint reconstruction market. Like kids playing the game...
More people die from sepsis than from prostate cancer, breast cancer, and AIDS combined. Yet only a little more than half of American adults have even heard of sepsis.